Exchange: NYSEMkt·Updated 07:30 PM EDT

NSRX Nasus Pharma Ltd.

$3.63
$0.12
(3.31%)
Today
Closed $3.51
$0.12
(3.42%)
After Hours
Mkt Cap$42.51M
Vol16,921.00

About NSRX

Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
52

Neutral Sentiment

How do you feel about NSRX?

Winorbust
$NSRX $PPBT anything that has any members from PPBT becomes a good shorting stock because the execs in PPBT are scam artists
Stock_Catcher
$NSRX Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis

Advertisement|Remove ads.